✨ Your Portfolio is fetched and updated from zerodha.
Nano Miscellaneous

Welcure Drugs & Pharmaceuticals Ltd.

WELCURE

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹62 Cr.
P/E
1.78

Welcure Drugs & Pharmaceuticals Ltd.

  • Welcure Drugs&Pharma
  • Biogen Pharmachem
  • Mishka Exim

FAQs on Welcure Drugs & Pharmaceuticals Ltd. Shareprice

Welcure Drugs&Pharma has given better returns compared to its competitors.
Welcure Drugs&Pharma has grown at ~37.9% over the last 7yrs while peers have grown at a median rate of 19.01%

Welcure Drugs&Pharma is not expensive.
Latest PE of Welcure Drugs&Pharma is 1.78, while 3 year average PE is 142.
Also latest EV/EBITDA of Welcure Drugs&Pharma is 4.2 while 3yr average is 91.07.

View FAQ's On Business

Growth Table

  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Balance Sheet

  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Cash Flow

  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Quarterly Results

  • Welcure Drugs & Pharmaceuticals Ltd.
  • Biogen Pharmachem
  • Mishka Exim

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Welcure Drugs & Pharmaceuticals Ltd. Financials

Welcure Drugs&Pharma balance sheet is weak and might have solvency issues

Yes, The net debt of Welcure Drugs&Pharma is increasing.
Latest net debt of Welcure Drugs&Pharma is ₹123 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹123 Crs.

Yes, profit is increasing.
The profit of Welcure Drugs&Pharma is ₹34.76 Crs for TTM, ₹2.17 Crs for Mar 2025 and -₹0.17 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Welcure Drugs&Pharma latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech